The stock of Alphatec Holdings Inc (NASDAQ:ATEC) is a huge mover today! The stock increased 4.28% or $0.22 on November 23, hitting $5.36. About 165,917 shares traded hands or 149.75% up from the average. Alphatec Holdings Inc (NASDAQ:ATEC) has risen 86.11% since April 22, 2016 and is uptrending. It has outperformed by 80.70% the S&P500.
The move comes after 9 months positive chart setup for the $45.97M company. It was reported on Nov, 24 by Barchart.com. We have $5.74 PT which if reached, will make NASDAQ:ATEC worth $3.22M more.
Analysts await Alphatec Holdings Inc (NASDAQ:ATEC) to report earnings on March, 21.
Alphatec Holdings Inc (NASDAQ:ATEC) Ratings Coverage
Out of 2 analysts covering Alphatec Holdings Inc. (NASDAQ:ATEC), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Alphatec Holdings Inc. has been the topic of 3 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Northland Capital downgraded the shares of ATEC in a report on Monday, March 14 to “Underperform” rating. Zacks downgraded the shares of ATEC in a report on Friday, August 7 to “Hold” rating. The firm earned “Hold” rating on Wednesday, August 5 by Canaccord Genuity.
According to Zacks Investment Research, “Alphatec Holdings, Inc. is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company’s principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. Alphatec Holdings, Inc. is headquartered in Carlsbad, California.”
Insitutional Activity: The institutional sentiment decreased to 0 in Q2 2016. Its down 0.67, from 0.67 in 2016Q1. The ratio is negative, as 8 funds sold all Alphatec Holdings Inc shares owned while 4 reduced positions. 3 funds bought stakes while 5 increased positions. They now own 14.37 million shares or 6.30% less from 15.34 million shares in 2016Q1.
Globeflex Ltd Partnership last reported 3,152 shares in the company. Geode Cap Mngmt Limited Liability Corporation has 306,249 shares for 0% of their US portfolio. Hightower Advsrs holds 118,375 shares or 0% of its portfolio. California Pub Employees Retirement Systems accumulated 0% or 107,400 shares. Deutsche Financial Bank Ag has invested 0% of its portfolio in Alphatec Holdings Inc (NASDAQ:ATEC). Kcg, a New Jersey-based fund reported 38,437 shares. Mycio Wealth Ltd Com owns 1,000 shares or 0% of their US portfolio. Wesbanco Bancorporation Inc holds 10,000 shares or 0% of its portfolio. Guggenheim Cap Limited Liability Company, a Illinois-based fund reported 31,101 shares. Blackrock Institutional Trust Na last reported 0% of its portfolio in the stock. Deerfield Mngmt reported 4.98 million shares or 0.07% of all its holdings. Spark Inv Management Limited Liability Com holds 0.01% or 263,500 shares in its portfolio. State Street Corp holds 0% of its portfolio in Alphatec Holdings Inc (NASDAQ:ATEC) for 32,677 shares. Royal Savings Bank Of Canada has 50,651 shares for 0% of their US portfolio. Finance Advisers Limited Liability Com has 0% invested in the company for 49,949 shares.
More recent Alphatec Holdings Inc (NASDAQ:ATEC) news were published by: Marketwatch.com which released: “/quotes/zigman/3870025/realtime” on December 21, 2009. Also Reuters.com published the news titled: “BRIEF-Alphatec Holdings announces one-for-twelve reverse stock split” on August 24, 2016. Streetinsider.com‘s news article titled: “Form 4 Alphatec Holdings, Inc. For: Nov 15 Filed by: Plunkett Michael Joseph” with publication date: November 18, 2016 was also an interesting one.
ATEC Company Profile
Alphatec Holdings, Inc., incorporated on March 4, 2005, is a medical technology company. The Firm through its subsidiary, Alphatec Spine, Inc. and its subsidiaries (Alphatec Spine), designs, develops, makes and markets products for the surgical treatment of spine disorders. The Company’s product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. The Company’s principal product offerings are focused on the global market for fusion spinal disorder solutions. The Company’s products include Cervical and Cervico-Thoracic Products; Thoracolumbar Fixation Products; Spinal Spacers; minimally invasive surgery (MIS) Products, and Biologics.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.